KDIGO研讨会报告:东亚家庭血液透析的实施与扩展——聚焦香港、日本、韩国和台湾
该报告总结2025年9月在日本川越举行的KDIGO一日研讨会,参会者包括肾脏病学利益相关方、医生、护士及接受家庭血液透析(HHD)的患者,旨在为东亚主要国家和地区制定扩展HHD的战略框架和路线图。报告指出HHD使用率低的原因包括中心血透文化强、医院基础设施、监管障碍、临床医生知识有限、家庭资源需求及患者对自我管理的恐惧,并详述研讨会内容及后续路线图。
要点
- 东亚HHD使用率低,受中心血透文化、基础设施、监管、知识及患者恐惧等多因素制约。
- KDIGO研讨会汇聚多方利益相关方,制定扩展HHD的战略框架和路线图。
- 报告旨在增加肾衰竭患者的治疗选择,推动东亚HHD的实施与扩展。
核心结论
- 东亚地区HHD使用率低,需通过战略框架和路线图扩展HHD以增加肾衰竭患者的治疗选择。
研究设计与样本
- 2025年9月在日本川越举行的1天KDIGO研讨会,参会者包括东亚肾脏病学利益相关方、医生、护士及接受HHD的患者。
主要发现
- HHD与中心肾脏替代治疗相比,患者自主性和治疗满意度更高,但东亚地区HHD使用水平低。
- HHD使用有限的原因包括强大的中心血透文化、医院基础设施、监管障碍、透析临床医生知识有限、家庭资源需求及患者对自我管理的恐惧。
临床怎么用
- 利用研讨会制定的战略框架和路线图,推动东亚地区HHD的实施与扩展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Home hemodialysis (HHD) is associated with greater patient autonomy and treatment satisfaction compared with in-center kidney replacement modalities, yet the level of HHD use is low, particularly in the East Asian region. Reasons for limited HHD use are a strong in-center hemodialysis (ICHD) culture, hospital-based infrastructure, regulatory barriers, limited knowledge among dialysis clinicians, home resource requirements, and patient-related fears regarding self-management. To redress the low HHD uptake in East Asia, a 1-day Kidney Disease: Improving Global Outcomes (KDIGO) workshop of key nephrology stakeholders, nephrologists, nurses, and individuals receiving HHD from East Asia was held in September 2025 in Kawagoe, Japan. The goals were to create a strategic framework and a roadmap for expanding HHD in key East Asian countries. This report details the workshop content and provides a roadmap for stakeholders to move forward, with the aim to increase the therapeutic options for people with kidney failure.
引用
- Masakane I, Bennett PN, Chao CT, et al. KDIGO Workshop Report on the Implementation and Expansion of Home Hemodialysis in East Asia: A Focus on Hong Kong, Japan, Korea, and Taiwan. Kidney Int Rep. 2026. PMID: 42518526. doi:10.1016/j.ekir.2026.106588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。